In our cohort of tumor specimens from patients with histologically confirmed PDAC, we observed a significant upregulation of cortactin and phosphorylated (i.e. activated) cortactin in metastases of PDAC patients as compared to primary tumors. The gene discussed is CTTN; the disease is neoplasm.